Cork company begins trading in London
Kinsale-based science research firm EiRx Therapeutics began trading in London today for the first time.
EiRx, which develops drugs that target cancer and inflammatory disease, was founded in 1999 by Professor Tom Cotter, head of biochemistry at UCC.





